Cranial Irradiation

Subscribe to Selected New Research on Cranial Irradiation

857 relevant articles (79 outcomes, 103 trials/studies) found for this Therapy

Description: The exposure of the head to roentgen rays or other forms of radioactivity for therapeutic or preventive purposes.

Also Known As:

Cranial Irradiations; Irradiation, Cranial; Irradiations, Cranial

Relationship Network

Therapy Context: Research Results

Therapeutics: 5195

Radiotherapy: 176

Cranial Irradiation: 857

Pituitary Irradiation: 123

Experts

1.	Gore, Elizabeth: 3 articles (01/2006 - 10/2004)
2.	Lackner, Herwig: 2 articles (05/2008 - 03/2007)
3.	Komaki, Ritsuko: 2 articles (02/2008 - 08/2006)
4.	Wenz, F: 2 articles (02/2008 - 02/2002)
5.	Pöttgen, Christoph: 2 articles (11/2007 - 02/2004)
6.	Stuschke, Martin: 2 articles (11/2007 - 02/2004)
7.	Eberhardt, Wilfried: 2 articles (11/2007 - 02/2004)
8.	Le Péchoux, C: 2 articles (01/2007 - 12/2003)
9.	Weitzman, Sheila: 2 articles (12/2006 - 01/2004)
10.	Shalet, Stephen M: 2 articles (09/2005 - 02/2005)

Related Diseases

1.	Small Cell Carcinoma (Small Cell Lung Cancer) 01/01/2000 - "SELECTION CRITERIA: Randomized trials comparing prophylactic cranial irradiation with no prophylactic cranial irradiation in patients with small cell lung cancer in complete remission" 01/01/2000 - "OBJECTIVES: This study aims to test whether prophylactic cranial irradiation prolongs survival of patients with small cell lung cancer in complete remission" 08/12/1999 - "METHODS: We analyzed individual data on 987 patients with small-cell lung cancer in complete remission who took part in seven trials that compared prophylactic cranial irradiation with no prophylactic cranial irradiation" 05/01/2008 - "Historically, chemotherapy has been the mainstay of treatment for small cell lung cancer, but more recent evidence from large meta-analyses have established the local control and overall survival advantages conferred by the addition of external beam thoracic radiotherapy in combination with chemotherapy for limited stage disease along with prophylactic cranial irradiation for complete responders" 01/01/2007 - "Prophylactic cranial irradiation (PCI) has become part of the standard treatment in patients with small cell lung cancer (SCLC) in complete remission" Get all the results and reference details, order at left...
2.	Neoplasm Metastasis (Metastasis) 10/01/1996 - "PATIENTS AND METHODS: Data from randomized trials and retrospective studies are critically analysed related to the incidence of central nervous system (CNS) metastases in limited disease patients in complete remission with or without prophylactic cranial irradiation" 10/15/2005 - "All patients who achieve complete remission should be considered for treatment with prophylactic cranial irradiation, owing to the high frequency of brain metastases in this disease" 12/01/2001 - "Patients in complete remission should have prophylactic cranial irradiation, which reduces the risk of brain metastases and of death from SCLC" 11/01/1987 - "In patients who achieved a complete remission, the administration of prophylactic cranial irradiation (PCI) significantly reduced the risk of developing brain metastases as the initial site of the relapse (log-rank P = 0.0034)" 02/01/1982 - "Cranial irradiation in patients who achieve complete remission delays or reduces the incidence of CNS metastases" Get all the results and reference details, order at left...
3.	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/01/2001 - "It is well known that prophylactic cranial irradiation is highly effective in preventing central nervous system (CNS) relapse of acute lymphoblastic leukemia (ALL)" 08/01/2005 - "RAH was assessed in 79 adult childhood ALL survivors in first complete remission who had received cranial irradiation 25 Gy (Group I, n = 53), 18 Gy (Group II, n = 10) or chemotherapy alone (controls, n = 16)" 11/01/2003 - "He had had prophylactic cranial irradiation at a total dose of 24 Gy for the treatment of acute lymphocytic leukemia at the age of 4. Following this, he was in a complete state of remission for 6 years" 01/01/1978 - "From April 1971 to September 1977, 94 children with acute lymphocytic leukemia, in whom a complete clinical and hematologic remission had been obtained received preventive cranial irradiation at the University Clinic for Radiotherapy of Vienna" 01/15/2000 - "The purpose of our study was to investigate the efficacy of an acute lymphoblastic leukemia (ALL)-type treatment with moderate-dose, prophylactic cranial irradiation and without local radiotherapy for childhood T-cell lymphoblastic lymphoma (T-LBL)" Get all the results and reference details, order at left...
4.	Leukemia 10/01/1988 - "The cumulative incidence of CNS leukemia at 4-year calculated by the Kaplan-Meier Method was 40.5% in Group I, 26.9% in Group II, and 14.5% in Group III. We concluded that the combination of cranial irradiation and intrathecal MTX and HDC was highly efficacious" 11/01/1995 - "They originated from 1193 consecutively newly diagnosed children between 1972 and 1982, in first continuous complete remission for at least 6 y after diagnosis, and were treated according to Dutch Childhood Leukemia Study Group protocols (70%) or institutional protocols (30%), all including cranial irradiation for CNS prophylaxis" 01/01/2006 - "Innovative treatment options are needed for children who develop CNS relapses after a short initial remission or after receiving cranial irradiation, and in any adults with CNS leukemia at diagnosis or relapse." 11/01/1989 - "Taking into account the multiple factors which influence the occurrence and the treatment of CNS leukemia, the results on this retrospective study suggests that (1) for patients without CNS involvement at diagnosis and for whom BMT is performed in first remission, cranial irradiation before BMT and posttransplant prophylactic CNS therapy can be omitted because of the low probability of CNS relapse after BMT (3.4%), when total-body irradiation (TBI) is included in the conditioning regimen; and (2) the difference observed between Allo-BMT and Auto-BMT patients with previous CNS involvement and undergoing BMT in first remission could indicate that graft-versus-host leukemia acts even in the CNS in Allo-BMT patients." 11/01/2000 - "PURPOSE: This study was designed to investigate the impact of multileaf collimator (MLC) on lens dose in children with leukemia undergoing cranial irradiation" Get all the results and reference details, order at left...
5.	Neoplasms (Cancer) 06/01/2006 - "In SCLC polychemotherapy is mandatory; in local tumor stages radiotherapy should be combined early on with chemotherapy, and in cases of complete remission, prophylactic cranial irradiation is indicated" 10/01/1994 - "Chest irradiation to the primary tumors at both the hili and the mediastinum was administered in standard fractions on days 2-12 in the first cycle of chemotherapy and on days 29-47 in the second cycle, with a total dose of 40-50 Gy. Prophylactic cranial irradiation was performed among complete remission (CR) or good partial remission (PR) patients after completion of the concurrent therapy" 08/01/1996 - "In this study, we demonstrate that sublethal whole body irradiation (WBI) or local cranial irradiation of the tumor-bearing host prior to the adoptive transfer of LN cells, activated with the superantigen, SEC2, augments therapeutic efficacy, whereas body irradiation with cranial shielding is ineffective" 01/01/2007 - "As already established in limited disease prophylactic cranial irradiation is now also indicated in extensive disease in case of any tumor remission" 05/01/1997 - "Additional studies are in progress to evaluate the toxicity and efficacy of sequences of cranial irradiation and enhanced chemotherapy in tumor-bearing rats." Get all the results and reference details, order at left...
183 Diseases and 857 more articles analyzed in the Research Interface, order at left...

Related Drugs and Biologics

1.	Methotrexate (Mexate)
2.	Cisplatin (Platino)
3.	Vincristine (Oncovin)
4.	Etoposide (VP 16)
5.	Cyclophosphamide (Cytoxan)
6.	6-Mercaptopurine (Mercaptopurine)
7.	Prednisone (Sone)
8.	Doxorubicin (Adriamycin)
9.	Growth Hormone (Somatotropin)
10.	Erythropoietin
92 Drugs and Important Bio-Agents and 202 more articles analyzed in the Research Interface, order at left...

Related Therapies and Procedures

1.	Drug Therapy (Chemotherapy)
2.	Combination Drug Therapy (Combination Chemotherapy)
3.	Transplants (Transplant)
4.	Nutritional Support (Artificial Feeding)
5.	Aftercare (After-Treatment)
17 Therapies and Procedures and 202 more articles analyzed in the Research Interface, order at left...

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>